Related Experiment Video
Updated: Jun 12, 2026
13:18
Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
Published on: April 10, 2026
Treatment-resistant depression in Hispanic patients
Alan Podawiltz1, Larry Culpepper
1Texas College of Osteopathic Medicine, and the Department of Psychiatry and Behavioral Health, University of North Texas Health Science Center, Fort Worth, USA.
The Journal of Clinical Psychiatry
|June 25, 2010
Summary
Many patients do not respond to initial antidepressant treatment. Spanish-speaking Hispanic individuals with major depression may experience poorer initial medication response compared to English speakers.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Approximately one-third of patients exhibit non-response to initial antidepressant therapy.
- Major depressive disorder (MDD) treatment outcomes can vary significantly across patient populations.
- Potential disparities in treatment response among Hispanic patients warrant further investigation.
Purpose of the Study:
- To summarize current understanding of antidepressant non-response.
- To highlight potential ethnic and linguistic differences in treatment efficacy for MDD.
- To discuss alternative and adjunctive treatment strategies for treatment-resistant depression.
Main Methods:
- Literature review of studies on antidepressant treatment outcomes.
- Analysis of factors influencing treatment response in major depression.
- Overview of non-pharmacological and novel therapeutic interventions.
Main Results:
- A significant proportion of patients require multiple medication trials for effective depression management.
- Evidence suggests Spanish-speaking Hispanic patients may have a less favorable initial response to antidepressants compared to English-speaking counterparts.
- Established alternative treatments and emerging options exist for non-responders.
Conclusions:
- Treatment resistance is a common challenge in managing major depression.
- Cultural and linguistic factors may impact antidepressant efficacy in specific patient groups.
- A patient-centered approach, exploring diverse therapeutic options, is crucial for optimizing outcomes in treatment-resistant depression.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:24Treatment Strategies for Psychological Disorders
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...